profit from every $100 of sales.

BriaCell Therapeutics Corp. Warrant expiring 2031
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
You pay $0.49 for every $1 of profit it makes in a year.
of earnings would pay off all its debt.
AI analysis
An AI analyst reads BriaCell Therapeutics Corp. Warrant expiring 2031's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 0.5×
- –
- –
- –
- –
- –
- –
- –
- 206.0%
- –
Profitability
- –
- –
- –
- –
- –
- 0.0%
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- +0.0%
Financial health
- –
- –
- –
- –
- –
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about BriaCell Therapeutics Corp. Warrant expiring 2031
Is BriaCell Therapeutics Corp. Warrant expiring 2031 a good stock to buy?
A business with weak numbers that is not profitable yet. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the BriaCell Therapeutics Corp. Warrant expiring 2031 AI analysis
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.